Christopher James Dubey, Psychiatric Survivor podcast

Comments on the Lindsay Clancy Case

0:00
3:25
Recuar 15 segundos
Avançar 15 segundos

Note: I drafted this with help from Grok, Google Gemini, and Claude to quickly elaborate on my thoughts before the trial concludes. Voiceover by Luvvoice.

Much of the public debate around the Lindsay Clancy trial has been squeezed into an artificial binary: either she was in acute, detached-from-reality psychosis, or she was entirely calculating and malice-driven.

It is entirely possible she was aware of what she was doing, and even that she exaggerated or misrepresented certain details—such as claiming she was experiencing command hallucinations ordering her to kill. But even if that claim is false, it does not disprove the severe impairment caused by the cascade of medications she was prescribed—effects that don’t simply vanish once a pill is stopped.

She was acting out of character for months, and that downward spiral coincided with when the prescriptions began and were changed.

Before she began taking the new medications in mid-October 2022, she was already dealing with postpartum anxiety, insomnia, low mood, and racing thoughts after the birth of her third child—symptoms that were real but still in a range many mothers manage without a rapid succession of psychiatric drugs. Family members consistently confirmed the behavioral changes she reported.

Her lawsuit against providers also points to earlier episodes—after her second and third children—that some argue looked like hypomania and should have prompted a bipolar workup. If anything, that history cuts the other way: a person with undiagnosed bipolar vulnerability is more susceptible to exactly the kind of destabilization that rapid antidepressant and benzodiazepine cycling can cause, not less.

A person does not need command hallucinations or complete detachment from reality to be significantly impaired. She received a large number of prescriptions from multiple providers over a few months—antidepressants, benzodiazepines, an antipsychotic, and others—with frequent starts, stops, and overlaps. She was not taking 13 medications simultaneously, but the rapid cycling itself created the kind of neurochemical instability that can persist even after individual drugs are discontinued. Neuronal receptor destabilization, acute withdrawal, and medication-induced akathisia can leave someone agitated, emotionally blunted, and cognitively impaired—even while basic functioning appears superficially intact.

None of this minimizes the horrific tragedy or excuses the loss of three children’s lives. This case simply isn’t cut and dried.

It is also an urgent reminder of what the pharmaceutical industry has known for decades: rapid medication changes and polypharmacy carry grave risks for vulnerable patients. Pharmaceutical companies have routinely downplayed adverse effects, misleading clinicians, medical schools, regulatory agencies, and the public.

While a legal reckoning in court is warranted, the pharmaceutical industry shares culpability for fostering inadequate informed consent and leaving patients and clinicians unprepared for severe drug-induced crises.

For insights on this case with Dr. David Healy, who has testified in major litigation regarding antidepressant adverse effects, see this episode of The HighWire with Jefferey Jaxen:

https://thehighwire.com/ark-videos/the-download-ca-attacks-journalism-the-clancy-controversy-mrnas-cancer-cure/



This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit chrisjamesdubey.substack.com

Mais episódios de "Christopher James Dubey, Psychiatric Survivor"